While Wanner et al. [28] and Sun et al. [29] reported the synthesis of hybrid O6-BG-DNA targeting molecules, this is the first report on the design and mechanism of action of a dual EGFR-MGMT targeted molecule in tumour cells. The gene discussed is MGMT; the disease is neoplasm.